October 2 (WNN) — The Food and Drug Administration will hold three committee meetings this month on COVID-19 booster shots and vaccines for children.
The FDA on Friday announced two advisory committee meetings on Janssen and Moderna COVID-19 Vaccine Boosters, and one related to Pfizer’s anticipated request from the FDA to allow the use of its COVID-19 vaccine on children. Amend the emergency use authorization request, 5 -1 1.
The first two meetings on booster shots will be on October 14 and October 15.
During the second meeting, the committee will also hear a National Institutes of Health presentation on the safety and efficacy of receiving an initial dose of a COVID-19 vaccine and a subsequent booster dose of another manufacturer’s shot.
FDA authorizes Pfizer-BioNTech COVID-19 booster dose for individuals 65 years of age and older who are at high risk for severe COVID-19 and who have persistent institutional or occupational exposure putting them at higher risk of severe COVID-19. 22.
Jeff Gents, coordinator of the White House Coronavirus Response Team, said Friday that nearly 2 million US residents received booster shots in their first week of eligibility.
The third meeting will take place on October 26 at Pfizer’s anticipated request.
“We know from our vast experience with our pediatric vaccines that children are not young adults, and we are using the presented clinical trial data to support the safety and effectiveness of the vaccine used in the young pediatric population. Will evaluate,” Janet Woodcock, acting FDA commissioner, said in a statement.
The announcement comes amid a grim milestone of 700,000 COVID-19 deaths in the country since the pandemic began on Friday and concerns about going into the winter months.